The supplemental New Drug Application is supported by Phase III data, which showed Caplyta significantly prolonged time to ...

While the growing oncology pipeline offers tremendous potential, the path from clinical development through to commercial ...

Ekterly becomes the first FDA-approved oral on-demand treatment for hereditary angioedema in patients aged 12 years and older ...

Biljana Naumovic, US President, oncology, solid tumor, Johnson & Johnson Innovative Medicine, outlines how the company is ...

The National Alliance on Mental Illness (NAMI) issued a response to the bill, stating that the cuts to Medicare and Medicaid ...

Traditionally, COVID vaccines have been delivered via injections. According to the Cincinnati Children’s Hospital Medical ...

Bayer-Tsinghua Collaboration Extended: Bayer renews its strategic partnership with Tsinghua University for three more years to accelerate drug discovery in oncology, cardiovascular, neurology, rare ...

FDA Accelerated Approval for Datroway: Datroway (datopotamab deruxtecan) has received accelerated approval in the United States for advanced EGFR-mutated non-small cell lung cancer after prior EGFR ...

Organizations like the Alzheimer’s Drug Discovery Foundation (ADDF) have always been an important part of the life sciences industry. As a venture philanthropy, it seeks out promising early-stage drug ...

Does Novo Nordisk support compounded GLP-1s? However, companies like Novo Nordisk have raised concerns when it comes to compounding. For drugs as popular as GLP-1s, there is a risk that some ...

NXT007 shows promise in hemophilia A treatment: Early Phase I/II data reveal zero treated bleeds in highest-dose cohorts, indicating potential for hemostatic normalization. Favorable safety profile ...

First and only daily disposable lens for multifocal astigmatism: Acuvue Oasys Max 1-Day Multifocal for Astigmatism is the first lens designed to correct both presbyopia and astigmatism in a daily ...